Tag

radiopharmaceutical florbetapir
03
Apr

Study: FDG-PET reigns supreme for assessing Alzheimer’s

FDG-PET is superior to amyloid PET imaging with the radiopharmaceutical florbetapir for assessing cognitive decline in patients with Alzheimer's disease or mild cognitive impairment. By Erik L. Ridley, AuntMinnie staff writer

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.